SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950133-03-003831
Filing Date
2003-11-12
Accepted
2003-11-12 17:19:39
Documents
6
Period of Report
2003-10-28
Items
Item 2: Acquisition or disposition of assets
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K w91648e8vk.htm 8-K 19717
3 EXHIBIT 2.01 w91648exv2w01.txt EX-2.01 257738
4 EXHIBIT 2.02 w91648exv2w02.txt EX-2.02 93531
5 EXHIBIT 2.03 w91648exv2w03.txt EX-2.03 53546
6 EXHIBIT 2.04 w91648exv2w04.txt EX-2.04 244477
7 EXHIBIT 99.1 w91648exv99w1.txt EX-99.1 10795
  Complete submission text file 0000950133-03-003831.txt   681867
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23736 | Film No.: 03994956
SIC: 2834 Pharmaceutical Preparations